Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Avery Dennison | AVY | 5. nov 2024 | 206.75 | +0.57 |
Axon Enterprise | AXON | 5. nov 2024 | 441.09 | +2.21 |
Baker Hughes A | BKR | 5. nov 2024 | 38.58 | +1.07 |
Ball | BALL | 5. nov 2024 | 59.98 | +0.87 |
Bank Of America | BAC | 5. nov 2024 | 41.88 | +1.33 |
Bank Of New York Mellon | BK | 5. nov 2024 | 76.01 | +1.35 |
Baxter International | BAX | 5. nov 2024 | 36.10 | +0.84 |
Becton, Dickinson And Co | BDX | 5. nov 2024 | 237.30 | +1.27 |
Berkshire Hathaway B | BRK-B | 5. nov 2024 | 445.06 | +0.63 |
Best Buy | BBY | 5. nov 2024 | 92.84 | +0.02 |
Bio-Techne | TECH | 5. nov 2024 | 77.62 | +2.27 |
Biogen | BIIB | 5. nov 2024 | 176.93 | +1.97 |
BlackRock | BLK | 5. nov 2024 | 1 014.35 | +2.30 |
Blackstone | BX | 5. nov 2024 | 169.62 | +1.54 |
Boeing | BA | 5. nov 2024 | 151.00 | -2.62 |
Booking | BKNG | 5. nov 2024 | 4 914.98 | +2.90 |
BorgWarner | BWA | 5. nov 2024 | 34.02 | +1.70 |
Boston Properties | BXP | 5. nov 2024 | 81.38 | +1.31 |
Boston Scientific | BSX | 5. nov 2024 | 85.54 | +0.97 |
Bristol-Myers Squibb | BMY | 5. nov 2024 | 55.95 | +0.90 |
Broadcom | AVGO | 5. nov 2024 | 173.90 | +3.17 |
Broadridge Financial Solutions | BR | 5. nov 2024 | 218.30 | +4.13 |
Brown & Brown | BRO | 5. nov 2024 | 107.60 | +2.04 |
Brown Forman B | BF-B | 5. nov 2024 | 43.74 | -0.11 |
Builders Firstsource | BLDR | 5. nov 2024 | 180.99 | +4.96 |
Bunge | BG | 5. nov 2024 | 84.80 | +0.95 |
C.H. Robinson Worldwide | CHRW | 5. nov 2024 | 104.93 | +2.22 |
Cadence Design Systems | CDNS | 5. nov 2024 | 291.21 | +0.65 |
Caesars Entertainment | CZR | 5. nov 2024 | 38.79 | -2.17 |
Camden Property Trust | CPT | 5. nov 2024 | 118.00 | +1.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.